MedTrace Logo

Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS

NCT00761683 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2009-09-10

No results posted yet for this study

Summary

To observe the effect of goserelin 3,6mg sc depot injection by assessment of the mean percent reduction scores for symptoms: dysmenorrhoea, dyspareunia and pelvic pain; to observe the effect of goserelin 3,6mg sc depot injection by assessment of the mean percent reduction scores for pelvic tenderness and indurations; to observe the reduction in the proportion of patients requiring analgesics for the relief of pelvic pain for 6 months in patients treated with Zoladex 3.6 mg.

Conditions

  • Endometriosis

Sponsors & Collaborators

Principal Investigators

  • Cristina Pentiuc · AstraZeneca Romania

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31

Countries

  • Romania

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00761683 on ClinicalTrials.gov